Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Tailored Antiplatelet Initiation to Lesson Outcomes Due to Decreased Clopidogrel Response After Percutaneous Coronary Intervention (TAILOR-PCI)

Trial Profile

Tailored Antiplatelet Initiation to Lesson Outcomes Due to Decreased Clopidogrel Response After Percutaneous Coronary Intervention (TAILOR-PCI)

Recruiting
Phase of Trial: Phase IV

Latest Information Update: 14 Feb 2019

At a glance

  • Drugs Clopidogrel (Primary) ; Ticagrelor (Primary)
  • Indications Acute coronary syndromes; Coronary artery disease; Thrombosis
  • Focus Therapeutic Use
  • Acronyms TAILOR-PCI
  • Most Recent Events

    • 04 Feb 2019 Planned primary completion date changed from 1 Sep 2019 to 1 Nov 2019.
    • 31 Aug 2018 Biomarkers information updated
    • 24 Nov 2015 Planned End Date changed from 1 Aug 2016 to 1 Mar 2020 as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top